Fatty liver disease is a condition that can be caused by being overweight or obese. Here are five warning signs of fatty ...

However, just months after the IPO, on December 6, 2024, the company announced it was halting the trial after some participants experienced elevated liver enzymes, a condition known as transaminitis.

It’s been a rocky few months for BioAge Labs, which shuttered a Phase II trial of its lead candidate azelaprag Tuesday after ...

BioAge Labs has given up on its lead obesity candidate. Weeks after stopping a trial in response to phase 2 data, the biotech has jettisoned the molecule and shifted its focus to a preclinical ...

Major barriers in screening for fatty liver disease in patients with HIV included uncertainties about testing, diagnostic ...

Elevated liver enzymes can occur for many reasons. Most often, elevated liver enzymes are temporary and resolve on their own without treatment. Occasionally, elevated liver enzymes require additional ...

Investing.com -- Barclays downgraded Ford Motor (NYSE:F) to Equal Weight from Overweight in a note Wednesday, citing concerns about elevated volume headwinds and uncertainty surrounding the ...

Fatty liver disease, or hepatic steatosis, occurs when excess fat accumulates in liver cells. Commonly associated with ...

This makes the results published by Almut Schulze and colleagues from the German Cancer Research Center (DKFZ) all the more surprising: when the researchers blocked the enzyme aldolase A, which ...

Rubisco is the enzyme responsible for carbon fixation in plants, algae and many bacteria. A screen of a comprehensive library of rubisco variants (each with a different single-amino-acid mutation ...

Be among those who shape the future with knowledge. Uncover exclusive stories that captivate your mind and heart with our FREE 14-day subscription trial. Dive into a world of inspiration, learning, ...